BRIEF published on 03/26/2026 at 16:25, 3 months 30 days ago Sartorius AG Extends René Fáber's Board Appointment Executive Board Sartorius AG Bioprocess Solutions Appointment Extension René Fáber
PRESS RELEASE published on 03/26/2026 at 16:20, 3 months 30 days ago Sartorius AG Supervisory Board extends appointment of board member René Fáber Sartorius AG extends Dr. René Fáber's appointment on the Board until Dec 31, 2031, reinforcing the Bioprocess Solutions Division leadership. Learn more about Sartorius AG's latest decision here Supervisory Board Sartorius AG Appointment Extension René Fáber Bioprocess Solutions Division
BRIEF published on 03/26/2026 at 15:28, 3 months 30 days ago Sartorius AG Concludes Annual General Meeting with Key Resolutions Financial Results Annual General Meeting Life Sciences Sartorius Dividends
PRESS RELEASE published on 03/26/2026 at 15:23, 3 months 30 days ago Sartorius AG - Resolutions of the Annual General Meeting Sartorius AG's Annual General Meeting results approved dividend of 0.74 euros per preference share and 0.73 euros per ordinary share. Next financial reports in April, July, and October 2026 Annual General Meeting Dividend Financial Reports Biopharmaceutical Sartorius AG
BRIEF published on 03/17/2026 at 07:04, 4 months 8 days ago Sartorius Intensifies Biopharma Strategy with Ambitious Growth Targets Operational Efficiency Growth Targets Bioprocess Solutions Sales Revenue Growth Biopharma Strategy
PRESS RELEASE published on 03/17/2026 at 06:59, 4 months 8 days ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets at Capital Markets Day in Göttingen, Germany Sartorius Strategy Capital Markets Day Growth Targets Biopharma Focus
BRIEF published on 03/16/2026 at 14:09, 4 months 9 days ago Sartorius Unveils New Platform to Enhance Cell Therapy Production Cost Reduction Manufacturing Efficiency Cell Therapy Platform Eveo Launch Sartorius Innovation
PRESS RELEASE published on 03/16/2026 at 14:04, 4 months 9 days ago Sartorius launches next-generation platform to boost efficiency in cell therapy production Sartorius launches next-generation platform for efficient cell therapy production, enabling cost reduction and scalability. Integrated system addresses manufacturing challenges Sartorius Cell Therapy Production Efficiency Manufacturing Costs Eveo Platform
BRIEF published on 02/16/2026 at 10:41, 5 months 9 days ago Sartorius Enhances Climate Targets with SBTi Validation Net-zero Emissions Sartorius Sustainable Energy Science Based Targets Climate Targets
PRESS RELEASE published on 02/16/2026 at 10:36, 5 months 9 days ago Sartorius sharpens climate targets and receives validation from Science Based Targets initiative Sartorius sharpens climate targets with Science Based Targets initiative validation, aiming for net-zero emissions by 2045. Transitioning to renewable energy & sustainable practices Net-zero Emissions SBTi Sartorius Climate Targets Science-based
Published on 07/25/2026 at 00:35, 23 hours 27 minutes ago Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 1 day 1 hour ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 1 day 1 hour ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 1 day 1 hour ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 1 day 4 hours ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/24/2026 at 18:44, 1 day 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 17:50, 1 day 6 hours ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 17:40, 1 day 6 hours ago 2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of May 31, 2026.
Published on 07/24/2026 at 18:50, 1 day 5 hours ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 08:00, 1 day 16 hours ago Accor signs a definitive binding agreement on the sale of its stake in Essendi
